Shenzhen BioX Medical Co., Ltd. stands as a beacon of innovation in the global Point-of-Care Testing (POCT) and molecular diagnostic landscape. Established in 2017 and headquartered in Shenzhen—the "Silicon Valley of Hardware" and a global epicenter for biotechnology—BioX Medical has rapidly evolved into a leading professional manufacturer specializing in molecular diagnostic analysis systems, genetic testing solutions, and clinical laboratory equipment.
Our commitment to E-E-A-T (Experience, Expertise, Authoritativeness, and Trustworthiness) is reflected in our robust infrastructure. Spanning over 9,000 square meters of state-of-the-art manufacturing space, our facility is equipped with automated assembly lines and ISO-certified cleanrooms. With a dedicated workforce of over 200 experts, we bridge the gap between complex laboratory science and practical clinical application.
The global healthcare industry is witnessing a decisive shift from centralized hospital laboratories to decentralized, "patient-centric" diagnostic models. Point-of-Care Health Solutions are at the heart of this transformation. As an industry-leading exporter, BioX Medical addresses the increasing demand for rapid, accurate, and cost-effective diagnostics in Europe, North America, the Asia-Pacific region, the Middle East, Latin America, and Africa.
In developed markets, our solutions focus on workflow optimization and precision medicine. Conversely, in developing regions, we provide critical diagnostic accessibility, enabling high-quality testing in areas with limited infrastructure. Our ability to offer flexible OEM and ODM services allows us to customize diagnostic platforms to meet specific regional regulatory requirements and healthcare priorities.
Our Real-Time PCR systems and automated extraction platforms allow hospitals to reduce turnaround time (TAT) for critical infectious disease testing from days to hours, facilitating immediate treatment decisions.
Compact and portable POCT devices are utilized in ambulances and rural health clinics, where "golden hour" diagnostics can save lives during viral outbreaks or acute health crises.
Localized testing isn't limited to humans. Our FIPV rapid test kits and plant disease diagnosis instruments provide farmers and veterinarians with tools to prevent the spread of pathogens in livestock and crops.
The future of Point-of-Care diagnostics is defined by three pillars: Miniaturization, Automation, and Digitization. BioX Medical's technical roadmap is focused on integrating these trends to provide unprecedented Information Gain to healthcare providers.
1. Microfluidic Integration: We are transitioning from traditional laboratory-on-a-bench to Lab-on-a-Chip (LoC) technology. This reduces reagent consumption and simplifies user operation, making molecular testing as easy as a glucose test.
2. AI-Driven Analytics: By embedding Artificial Intelligence into our imaging systems (like the Automatic Gel Imaging System), we provide automated defect detection and biomarker quantification, removing human error from the diagnostic equation.
3. Cold-Chain Independence: One of our primary R&D goals is the development of lyophilized (freeze-dried) reagents that remain stable at room temperature, eliminating the logistical hurdle of cold-chain transport in tropical or remote regions.
Our location in Shenzhen provides a unique competitive advantage known as "Supply Chain Vertical Integration." This allows us to maintain the highest quality standards while optimizing production costs and lead times.
Navigating international healthcare regulations requires deep expertise. BioX Medical provides comprehensive support to ensure our partners remain compliant with local laws.
We provide CE, ISO 13485, and various FDA-equivalent certifications across our product lines. Furthermore, our support extends beyond the sale: we offer localized training modules, multi-language software interfaces, and 24/7 technical support to ensure that local health workers can operate our equipment with confidence and precision.
Shenzhen BioX Medical Co., Ltd. serves a diverse and growing global clientele. By integrating advanced automation, sophisticated data management capabilities, and laboratory workflow optimization, we develop solutions that significantly improve testing efficiency, analytical accuracy, and operational reliability.
Our multidisciplinary team of engineers and laboratory specialists ensures that every piece of equipment—from nucleic acid extraction systems to high-precision lifting platforms—is built to last and perform. As we continue to invest in innovation, we invite healthcare providers, biotechnology companies, and distributors worldwide to join us in advancing the frontiers of molecular diagnostics and precision healthcare.
BioX Medical
